Conmed (CNMD) Tops Q2 EPS by 3c ; Offers Guidance

Conmed (NYSE: CNMD) reported Q2 EPS of $1.15, $0.03 better than the analyst estimate of $1.12. Revenue for the quarter came in at $342.34 million versus the consensus estimate of $338.4 million.

GUIDANCE:

Conmed sees FY2025 revenue of $1.36-1.39 billion, versus the consensus of $1.36 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.

You May Also Be Interested In

• Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
• Bill.com (BILL) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 Guidance
• Etsy upgraded to buy at BofA on durable growth, buyback potential